All Projects → sigven → oncoPharmaDB

sigven / oncoPharmaDB

Licence: MIT license
Targeted and non-targeted anticancer drugs and drug regimens

Programming Languages

r
7636 projects
TeX
3793 projects
python
139335 projects - #7 most used programming language

Projects that are alternatives of or similar to oncoPharmaDB

chemicalx
A PyTorch and TorchDrug based deep learning library for drug pair scoring.
Stars: ✭ 176 (+700%)
Mutual labels:  drug
hotspot3d
3D hotspot mutation proximity analysis tool
Stars: ✭ 43 (+95.45%)
Mutual labels:  drug
muler
A search engine for drug information built with Flask.
Stars: ✭ 56 (+154.55%)
Mutual labels:  drug
MetaOmGraph
MetaOmGraph: a workbench for interactive exploratory data analysis of large expression datasets
Stars: ✭ 30 (+36.36%)
Mutual labels:  cancer-data
PharmacoDB
Search across publicly available datasets to find instances where a drug or cell line of interest has been profiled.
Stars: ✭ 38 (+72.73%)
Mutual labels:  drug-targets
GLaDOS
Web Interface for ChEMBL @ EMBL-EBI
Stars: ✭ 28 (+27.27%)
Mutual labels:  drug-targets
The-Cancer-Targetome
Initial data release for drug-target interactions of the cancer targetome.
Stars: ✭ 12 (-45.45%)
Mutual labels:  drug-targets
NDD
Drug-Drug Interaction Predicting by Neural Network Using Integrated Similarity
Stars: ✭ 25 (+13.64%)
Mutual labels:  drug-target-interactions

 

pharmOncoX

pharmOncoX is an R package that provides access to targeted and non-targeted cancer drugs, including comprehensive annotations per target, drug mechanism-of-action, approval dates, clinical trial phases for various indications etc.

Getting started

Contact

sigven AT ifi.uio.no

Code of Conduct

Please note that this project is released with a Contributor Code of Conduct. By participating in this project you agree to abide by its terms.

Note that the project description data, including the texts, logos, images, and/or trademarks, for each open source project belongs to its rightful owner. If you wish to add or remove any projects, please contact us at [email protected].